3 results
Primary(Part I and Part II):- To determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) in the QW and/or Q3W regimens of RO7122290 in combination with cibisatamab after pretreatment with obinutuzumab- To characterize the…
The primary aim of this study is to evaluate the feasibility and safety of In-111-PSMA I&T radio guided surgery in patients diagnosed with prostate cancer who are highly suspected of having pelvic lymph node metastasis based on pre-operative…
To investigate if the use of weekly low dose cisplatin increases compliance to the planned chemotherapy scheme in LA-HNSCC patients with low SMM to a level of compliance to three-weekly high dose cisplatin of patients without low SMM. We hypothesize…